| Takeda Pharma AG - Feiba NF 2500 E., Injektionspräparat |
| 41352 | | 05 | | Feiba NF 2500 E. | | Injektionspräparat | | B02BD03 | | Factor Viii Inhibitor Bypassing Activity | | 30.09.2010 | | |
|
| Composition |
| Praeparatio cryodesiccata: proteinorum plasmatis humani solutio 1000-3000 mg corresp. F.E.I.B.A. 2500 U., natrii citras dihydricus, natrii chloridum, pro praeparatione.
Solvens: aqua q.s. ad solutionem pro 50 ml. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Injection preparation | | | | | | | | Active Agent | Dose |
|---|
| Proteinorum Plasmatis Humani Solutio | 1000-3000 mg correspond Factor Eight Inhibitor Bypassing Activity (feiba) 2500 U |
| | BAG: Active Agent | Dose |
|---|
| Human-Plasmaproteine mit Faktor VIII-Inhibitor Bypass Aktivität | 2500 U |
| | | | Inactive agents |
|---|
| Sodium Chloride | | Natrii Citras Dihydricus |
| |
| Solvens | | | aqua q.s. ad solutionem pro 50 ml | | | | | | BAG: Active Agent | Dose |
|---|
| Human-Plasmaproteine mit Faktor VIII-Inhibitor Bypass Aktivität | 2500 U |
|
| Solvens | | | aqua q.s. ad solutionem pro 50 ml | | | | | | BAG: Active Agent | Dose |
|---|
| Human-Plasmaproteine mit Faktor VIII-Inhibitor Bypass Aktivität | 2500 U |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 036 | ampoule(s) | 3460.73 | 3591.75 | B | SL | Yes |
|
